Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential ...
It could signal major changes in compliance, grants and oversight for state and local governments. That’s happened in the ...
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The ...
- Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission framework granted to Alpha Tau by the FDA allows for streamlined review and ...
Novocure exits 2025 having achieved record annual revenue, providing the financial strength to execute on the exciting growth opportunities we have in 2026,” said Frank Leonard, CEO, Novocure. “We ...
Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer baseAdvance SeaStar Medical’s ...
Our experts explain the science behind red light therapy, and if it really works. Plus, we recommend some FDA-cleared red ...
Indonesia Issues BKPM Regulation No. 5 of 2025 to Implement Updated Risk-Based Business Licensing Framework. Legal News and ...
Add Yahoo as a preferred source to see more of our stories on Google. Chronic bronchitis is the most common subgroup within COPD. Credit: Orawan Pattarawimonchai / Shutterstock.com. (Orawan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback